Recurrence and restart of sirolimus in vascular anomalies after withdrawal.

Liu, Hongyuan; Yang, Xi; Jia, Hechen; Hu, Li; Xu, Zian; Chen, Hui; Lin, Xiaoxi

Liu, Hongyuan; Yang, Xi; Jia, Hechen; Hu, Li; Xu, Zian; Chen, Hui; Lin, Xiaoxi.

Afiliación

Liu H; Plastic and Reconstructive Department, Shanghai Ninth People's Hospital, Shanghai, China.
Yang X; Plastic and Reconstructive Department, Shanghai Ninth People's Hospital, Shanghai, China.
Jia H; Plastic and Reconstructive Department, Shanghai Ninth People's Hospital, Shanghai, China.
Hu L; Plastic and Reconstructive Department, Shanghai Ninth People's Hospital, Shanghai, China.
Xu Z; Plastic and Reconstructive Department, Shanghai Ninth People's Hospital, Shanghai, China.
Chen H; Plastic and Reconstructive Department, Shanghai Ninth People's Hospital, Shanghai, China.
Lin X; Plastic and Reconstructive Department, Shanghai Ninth People's Hospital, Shanghai, China.

J Dermatol ; 50(4): e119-e120, 2023 04.

Article en En | MEDLINE | ID: mdl-36440961

Asunto(s)

Enfermedades Vasculares; Malformaciones Vasculares; Humanos; Sirolimus/uso terapéutico; Inmunosupresores/efectos adversos; Malformaciones Vasculares/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Vasculares / Malformaciones Vasculares Límite: Humans Idioma: En Revista: J Dermatol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google